Evelo Biosciences Inc (EVLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EVLO | AMGN | VRTX | REGN | BMY |
| Company | Evelo Biosciences Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 0.0477 | 277.69 | 402.95 | 900.00 | 44.36 |
| High | 0.0477 | 278.52 | 403.92 | 921.51 | 44.42 |
| Low | 0.0477 | 276.30 | 400.39 | 891.30 | 43.67 |
| Last | 0.0477 | 276.14 | 399.16 | 906.78 | 43.45 |
| Change | +0.0002 | -1.23 | -2.98 | +3.30 | -0.76 |
| % Change | +0.42% | -0.44% | -0.74% | +0.37% | -1.72% |
| Volume | 306 | 102,891 | 58,864 | 85,068 | 785,234 |
| 20-Day Average Volume | 21,600 | 2,121,150 | 953,926 | 457,447 | 13,541,587 |
| Previous Close | 0.0475 | 277.37 | 402.14 | 903.48 | 44.21 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.0447 | 270.16 | 398.78 | 908.35 | 47.84 |
| 20-Day Raw Stochastic | 50.00% | 88.49% | 56.08% | 62.04% | 2.67% |
| 20-Day Relative Strength | 46.21% | 53.03% | 47.42% | 49.36% | 28.01% |
| Weighted Alpha | -84.79 | +14.71 | +14.57 | +20.37 | -36.77 |
| Today's Opinion | 88% Sell | 24% Sell | 8% Buy | 24% Buy | 88% Sell |
| Previous Opinion | 88% Sell | 24% Sell | 8% Buy | 8% Buy | 88% Sell |
| Last Month's Opinion | 80% Sell | 8% Sell | 40% Buy | 56% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +7.47% since 04/24/24 | +3.06% since 04/25/24 | +0.99% since 04/25/24 | +3.46% since 04/25/24 | -1.70% since 04/25/24 |
| Low | 0.0390 on 05/01/24 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 43.73 on 05/01/24 |
| High | 0.0500 on 05/01/24 | 279.84 on 05/01/24 | 406.95 on 05/01/24 | 921.51 on 05/02/24 | 45.38 on 04/29/24 |
| 1-Month | |||||
| %Chg | -5.00% since 04/01/24 | +0.52% since 04/02/24 | -1.91% since 04/02/24 | -3.47% since 04/02/24 | -16.69% since 04/02/24 |
| Low | 0.0350 on 04/05/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.73 on 05/01/24 |
| High | 0.0600 on 04/15/24 | 279.84 on 05/01/24 | 414.95 on 04/03/24 | 962.20 on 04/04/24 | 52.87 on 04/03/24 |
| 3-Month | |||||
| %Chg | +12.03% since 02/01/24 | -14.10% since 02/02/24 | -5.43% since 02/02/24 | -2.50% since 02/02/24 | -9.79% since 02/02/24 |
| Low | 0.0350 on 04/05/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.73 on 05/01/24 |
| High | 0.0700 on 02/28/24 | 329.72 on 02/05/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | -87.63% since 11/01/23 | +4.14% since 11/02/23 | +6.66% since 11/02/23 | +12.55% since 11/02/23 | -14.06% since 11/02/23 |
| Low | 0.0280 on 12/15/23 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 783.57 on 11/10/23 | 43.73 on 05/01/24 |
| High | 0.7600 on 11/16/23 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 902 | 148,774,592 | 103,936,712 | 99,167,768 | 89,618,088 |
| Shares Outstanding, K | 18,983 | 536,376 | 258,459 | 109,762 | 2,027,100 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -114,530,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 8,196,000,000 | 2,517,700,000 | 3,434,300,000 | 11,865,000,000 |
| Last Quarter Net Income | -12,360,000 | 767,000,000 | 968,800,000 | 1,159,600,000 | -11,911,000,000 |
| 60-Month Beta | 1.94 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.66 on 11/09/23 | 4.71 on 02/06/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 05/20/24 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.69 | 29.23 | 23.70 | 41.85 |